To assess these notions in more detail, we established 11β‐HSD1 and H6PDH muscle‐specific KO models, in which we would be able to examine global and tissue‐specific phenotypes in the context of metabolic disease such as glucocorticoid excess. The gene discussed is H6PD; the disease is metabolic disease.